tirzepatide semaglutide side effects GLP-1 drugs such as and are transforming obesity and diabetes care in India, but experts warn that improper use could lead to significant muscle loss. A new India-specific consensus highlights Semaglutide vs Tirzepatide for Weight

Accessed 9/10/2019

Book a Discovery Visit (link in bio) #GLP1 #WeightManagement #ObesityMedicine #MetabolicHealth #HealthyHabits #PhysicianLedCare #LifestyleMedicine #LongevityMedicine #PrimaryCareDoctor #MattWattoMD | Matthew Watto

So, in Picture 7, you see a list of symptoms reported by one of my patients

This is due to a lack of safety data and potential risks to the infant

Qsymia requires careful monitoring for interactions with MAO inhibitors, other stimulants, carbonic anhydrase inhibitors, and medications affecting kidney stone formation due to its topiramate component

More specifically, the SELECT trial revealed that the weight loss drug significantly reduces the risk of major adverse cardiac events (MACE) and heart failure in patients who are overweight or obese with atherosclerotic cardiovascular disease, regardless of heart failure presence or type